Who owns the THERAFLEX RX trademark?

The THERAFLEX RX trademark is owned by Supreme Enterprises International Corp.

What class is the THERAFLEX RX trademark registered in?

The THERAFLEX RX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for THERAFLEX RX?

The USPTO serial number for THERAFLEX RX is 88837562.

What is the registration number for THERAFLEX RX?

THERAFLEX RX is registered under USPTO registration number 6414229.

THE

USPTO Trademark Record

REGISTERED

THERAFLEX RX

SN 88837562·Reg 6414229·Filed Mar 17, 2020

Owner Supreme Enterprises International Corp

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

THERAFLEX RX (Serial No. 88837562), Registration No. 6414229, is a registered US trademark filed on Mar 17, 2020 by Supreme Enterprises International Corp. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Renewal window: July 13, 2027280 days remaining

Mark Intelligence

THERAFLEX RX (Reg. #6414229) is a registered US trademark that has been protecting its owner, Supreme Enterprises International Corp, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 17, 2020

SERIAL

88837562

REG#

6414229

REGISTERED

Jul 13, 2021

Owner

Applicant

Supreme Enterprises International Corp

Entity

Corporation

State

Address

#300, 12304 Santa Monica Blvd, Los Angeles, CA, 90025

Country

Attorney

NameDeborah J. Peckham

Law firm

Deborah J. Peckham Burns & Levinson, LLP

Docket

SEI-601

Address

125 High Street, Boston, MA 02110, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMar 17, 2020

Serial Number88837562

Registration No.6414229

Registration DateJul 13, 2021

Status DateJul 13, 2021

Published for OppositionApr 27, 2021

Mark TypeStandard characters

Attorney DocketSEI-601

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: May 01, 2010

First use in commerce: Aug 01, 2012

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 13, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Jul 13, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 27, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 27, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 07, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 25, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 24, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 24, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 24, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

FINAL REFUSAL WRITTEN

Jan 20, 2021

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Jan 20, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Jan 20, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 17, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 17, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 17, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jun 17, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 17, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 17, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 09, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 21, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 20, 2020

NEW APPLICATION ENTERED

THERAFLEX RX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Supreme Enterprises International Corp

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Deborah J. Peckham

Resources

Company